These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Mode of action of Van-M-02, a novel glycopeptide inhibitor of peptidoglycan synthesis, in vancomycin-resistant bacteria. Miura K; Yamashiro H; Uotani K; Kojima S; Yutsudo T; Lu J; Yoshida O; Yamano Y; Maki H; Arimoto H Antimicrob Agents Chemother; 2010 Feb; 54(2):960-2. PubMed ID: 19933802 [TBL] [Abstract][Full Text] [Related]
9. Glycopeptide antibiotic analogs for selective inactivation and two-photon imaging of vancomycin-resistant strains. Ariyasu S; Too PC; Mu J; Goh CC; Ding Y; Tnay YL; Yeow EK; Yang L; Ng LG; Chiba S; Xing B Chem Commun (Camb); 2016 Mar; 52(25):4667-70. PubMed ID: 26953360 [TBL] [Abstract][Full Text] [Related]
10. Mechanism of action of oritavancin and related glycopeptide antibiotics. Allen NE; Nicas TI FEMS Microbiol Rev; 2003 Jan; 26(5):511-32. PubMed ID: 12586393 [TBL] [Abstract][Full Text] [Related]
11. Vancomycin resistance: are there better glycopeptides coming? Linden PK Expert Rev Anti Infect Ther; 2008 Dec; 6(6):917-28. PubMed ID: 19053904 [TBL] [Abstract][Full Text] [Related]
13. Role of the glycopeptide framework in the antibacterial activity of hydrophobic derivatives of glycopeptide antibiotics. Printsevskaya SS; Pavlov AY; Olsufyeva EN; Mirchink EP; Preobrazhenskaya MN J Med Chem; 2003 Mar; 46(7):1204-9. PubMed ID: 12646030 [TBL] [Abstract][Full Text] [Related]
14. N'-(alpha-aminoacyl)- and N'-alpha-(N-alkylamino)acyl derivatives of vancomycin and eremomycin. II. Antibacterial activity of N'-(alpha-aminoacyl)- and N'-alpha-(N-alkylamino)acyl derivatives of vancomycin and eremomycin. Plattner JJ; Chu D; Mirchink EP; Isakova EB; Preobrazhenskaya MN; Olsufyeva EN; Miroshnikova OV; Printsevskaya SS J Antibiot (Tokyo); 2007 Apr; 60(4):245-50. PubMed ID: 17456974 [TBL] [Abstract][Full Text] [Related]
16. Breaking the Permeability Barrier of Escherichia coli by Controlled Hyperporination of the Outer Membrane. Krishnamoorthy G; Wolloscheck D; Weeks JW; Croft C; Rybenkov VV; Zgurskaya HI Antimicrob Agents Chemother; 2016 Dec; 60(12):7372-7381. PubMed ID: 27697764 [TBL] [Abstract][Full Text] [Related]
17. Chemical Screen for Vancomycin Antagonism Uncovers Probes of the Gram-Negative Outer Membrane. Klobucar K; Côté JP; French S; Borrillo L; Guo ABY; Serrano-Wu MH; Lee KK; Hubbard B; Johnson JW; Gaulin JL; Magolan J; Hung DT; Brown ED ACS Chem Biol; 2021 May; 16(5):929-942. PubMed ID: 33974796 [TBL] [Abstract][Full Text] [Related]
18. Surface Ligand Density of Antibiotic-Nanoparticle Conjugates Enhances Target Avidity and Membrane Permeabilization of Vancomycin-Resistant Bacteria. Hassan MM; Ranzoni A; Phetsang W; Blaskovich MA; Cooper MA Bioconjug Chem; 2017 Feb; 28(2):353-361. PubMed ID: 27959504 [TBL] [Abstract][Full Text] [Related]
19. Alkyl-Aryl-Vancomycins: Multimodal Glycopeptides with Weak Dependence on the Bacterial Metabolic State. Sarkar P; Basak D; Mukherjee R; Bandow JE; Haldar J J Med Chem; 2021 Jul; 64(14):10185-10202. PubMed ID: 34233118 [TBL] [Abstract][Full Text] [Related]
20. Genetic and Chemical-Genetic Interactions Map Biogenesis and Permeability Determinants of the Outer Membrane of Escherichia coli. Klobucar K; French S; Côté JP; Howes JR; Brown ED mBio; 2020 Mar; 11(2):. PubMed ID: 32156814 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]